Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Veracyte
VCYT
$3.42B
| $19.2M | ﹤0.01% |
698,418
+14,066
| +2% | +$340K |
|
|
AHRT
1627
AH Realty Trust
AHRT
$506M
| $19.2M | ﹤0.01% |
1,551,562
+124,204
| +9% | +$1.37M |
|
|
IRBT
1628
DELISTED
iRobot
IRBT
| $19.2M | ﹤0.01% |
495,151
+43,131
| +10% | +$1.53M |
|
1629
Talos Energy
TALO
$2.58B
| $19M | ﹤0.01% |
1,336,779
+114,506
| +9% | +$1.67M |
|
1630
Doximity
DOCS
$4.74B
| $18.9M | ﹤0.01% |
674,867
-24,199
| -3% | -$572K |
|
1631
Semtech
SMTC
$12.4B
| $18.9M | ﹤0.01% |
863,231
+81,825
| +10% | +$1.52M |
|
1632
SunCoke Energy
SXC
$789M
| $18.9M | ﹤0.01% |
1,760,914
+45,503
| +3% | +$434K |
|
1633
Mercury Insurance
MCY
$5.81B
| $18.8M | ﹤0.01% |
504,744
+14,688
| +3% | +$509K |
|
1634
Navient
NAVI
$867M
| $18.8M | ﹤0.01% |
1,009,708
-38,465
| -4% | -$671K |
|
1635
Dorian LPG
LPG
$1.95B
| $18.8M | ﹤0.01% |
427,986
+10,493
| +3% | +$390K |
|
1636
Brookdale Senior Living
BKD
$3B
| $18.7M | ﹤0.01% |
3,213,358
-303,509
| -9% | -$1.42M |
|
1637
Credo Technology Group
CRDO
$49.6B
| $18.7M | ﹤0.01% |
958,316
+111,957
| +13% | +$1.9M |
|
1638
Liberty Live Group Series C
LLYVK
$9.92B
| $18.6M | ﹤0.01% |
497,705
+19,582
| +4% | +$666K |
|
|
RDUS
1639
DELISTED
Radius Recycling
RDUS
| $18.6M | ﹤0.01% |
615,905
+51,968
| +9% | +$1.37M |
|
1640
B&G Foods
BGS
$299M
| $18.4M | ﹤0.01% |
1,757,114
+181,724
| +12% | +$1.68M |
|
1641
National Healthcare
NHC
$3.46B
| $18.4M | ﹤0.01% |
199,315
+25,193
| +14% | +$1.93M |
|
1642
Immunovant
IMVT
$8.64B
| $18.4M | ﹤0.01% |
437,080
+49,840
| +13% | +$1.83M |
|
1643
Ambarella
AMBA
$3.59B
| $18.3M | ﹤0.01% |
299,062
+4,593
| +2% | +$251K |
|
1644
Enterprise Financial Services Corp
EFSC
$2.4B
| $18.3M | ﹤0.01% |
410,498
-915
| -0.2% | -$35.8K |
|
1645
Mobileye
MBLY
$7.58B
| $18.3M | ﹤0.01% |
422,384
+11,617
| +3% | +$457K |
|
|
SWTX
1646
DELISTED
SpringWorks Therapeutics
SWTX
| $18.3M | ﹤0.01% |
501,067
+77,303
| +18% | +$2.02M |
|
1647
Rhythm Pharmaceuticals
RYTM
$7.98B
| $18.3M | ﹤0.01% |
397,685
+12,937
| +3% | +$408K |
|
1648
Enterprise Products Partners
EPD
$82.2B
| $18.3M | ﹤0.01% |
729,307
-27,551
| -4% | -$734K |
|
1649
Enerpac Tool Group
EPAC
$1.89B
| $18.3M | ﹤0.01% |
587,691
+9,109
| +2% | +$260K |
|
1650
Omnicell
OMCL
$1.72B
| $18.2M | ﹤0.01% |
483,443
+32,548
| +7% | +$1.2M |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.